共 50 条
- [11] Efficacy and safety of a fixed dose combination of glimepiride and metformin versus glimepiride when added in to insulin glargine in patients with type 2 diabetes[J]. DIABETOLOGIA, 2011, 54 : S422 - S422Lee, J. -M.Lee, J. -H.Park, S. -H.Kim, S. -J.Park, K. -Y.Lim, D. -M.Chun, S. -W.Lee, J. -M.Park, K. -S.
- [12] Hypoglycemia and postprandial glucose are lower with insulin glargine versus NPH insulin in older type 2 diabetes patients[J]. GERONTOLOGIST, 2004, 44 : 221 - 221Fritsche, ADailey, GLin, ZMurray, FHäring, HRosenstock, J
- [13] Replacement of NPH Insulin with Insulin Glargine Provided Significantly Better Glycemic Control in Patients with Type 2 Diabetes Uncontrolled on NPH Plus Oral Antihyperglycemic Drugs or Short-Acting Insulin[J]. DIABETES, 2011, 60 : A619 - A619Glinkina, IrinaShestakova, Marina
- [14] Insulin glargine versus NPH insulin in patients with type 1 diabetes[J]. DRUGS OF TODAY, 2003, 39 (11) : 867 - 876Ratner, R
- [15] Inhaled insulin plus insulin glargine versus biaspart insulin for type 2 diabetes[J]. AFRICAN JOURNAL OF DIABETES MEDICINE, 2010, 18 (02): : 18 - 18不详
- [16] The relationship between glycemic control and Hypoglycemia using insulin glargine-versus NPH insulin:: A meta-regression analysis in type 2 diabetes[J]. DIABETES, 2003, 52 : A149 - A150Yki-Järvinen, HHäring, HUJohnson, EArbet-Engels, CNguyen, HZeger, SRiddle, M
- [17] Quality of life is improved with insulin glargine plus lispro compared with NPH insulin plus regular human insulin in patients with Type 1 diabetes[J]. DIABETOLOGIA, 2004, 47 : A306 - A306Witthaus, EJohnston, PBradley, C
- [18] Cost-Effectiveness of Insulin Glargine Versus NPH Insulin for the Treatment of Type 1 and Type 2 Diabetes Modeling the Interaction between Hypoglycemia and Glycemic Control in Switzerland[J]. DIABETES, 2009, 58 : A517 - A518Greiner, Roger-AxelAzoulay, MarieBrandle, Michael
- [19] Insulin detemir improves glycemic control with reduced risk of hypoglycemia and weight loss in patients previously treated with insulin glargine or NPH insulin[J]. DIABETES, 2007, 56 : A573 - A573Meneghini, LuigiKoenen, ChristophRojas, PatrickSelam, Jean-Louis
- [20] Cost-effectiveness of insulin glargine versus NPH insulin for the treatment of Type 2 diabetes mellitus, modeling the interaction between hypoglycemia and glycemic control in Switzerland[J]. INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2011, 49 (03) : 217 - 230Braendie, M.Azoulay, M.Greiner, R. -A.